EBS
Emergent BioSolutions Inc.
8.49
300 x 8.35
100 x 8.38
bid
ask
+
0.21
2.54%
09:49 AM
timesize
Ytd-31.31%
1y19.41%
8.38
day range
8.49
5.62
52 week range
14.06
Open8.39Prev Close8.28Low8.38High8.49Mkt Cap438.05M
Vol24.89KAvg Vol809.80KEPS-0.19P/EN/AForward P/E2.73
Beta1.57Short Ratio4.54Inst. Own60.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning04-3050-d Avg8.37200-d Avg9.721yr Est12.00

EBS News

benzinga.com
Emergent BioSolutions Secures $52.7M U.S. Government Contract Modification For ACAM2000 Smallpox And

Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
globenewswire.com
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM20

GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announce

BioMendics Receives FDA Fast Track Designation for BM-3103 (TolaSure® Gel™) for Epidermolysis Bullosa Simplex
businesswire.com
BioMendics Receives FDA Fast Track Designation for BM-3103 (TolaSure® Gel™) for Epidermolysis Bullos

AKRON, Ohio--(BUSINESS WIRE)-- #BIO2026--BioMendics, LLC, a clinical-stage biotechnology company dev

benzinga.com
FDA Broadens Access to Over-The-Counter Naloxone Nasal Spray for Opioid Overdose

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

Emergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript
seekingalpha.com
Emergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Emergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
globenewswire.com
Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day to Help

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reachi

benzinga.com
Emergent BioSolutions Wins $64.5M U.S. HHS Contract Modification To Supply Botulism Antitoxin BAT Un

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has been awarded a contract modification va

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
globenewswire.com
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Hept

GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today ann

Emergent BioSolutions to Participate in Upcoming Investor Conferences
globenewswire.com
Emergent BioSolutions to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced

benzinga.com
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebo

https://www.cdc.gov/ebola/situation-summary/index.html

benzinga.com
Emergent BioSolutions Announces Saudi Approval For ACAM2000, Its Smallpox and Mpox Vaccine

Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food a

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
globenewswire.com
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mp

GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biode

Hantavirus cases spark surge in pharma and biotech stocks — here's why
cnbc.com
Hantavirus cases spark surge in pharma and biotech stocks — here's why

Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak.

Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript
seekingalpha.com
Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript

Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript

Emergent BioSolutions Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Emergent BioSolutions Q1 2026 Earnings Call: Complete Transcript

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Emergent BioSolutions Sees Q2 Sales $170.000M-$185.000M vs $186.000M Est

Emergent BioSolutions (NYSE:EBS) sees Q2 sales of $170.000 million-$185.000 million vs $186.000 mill

benzinga.com
Emergent BioSolutions Affirms FY2026 Sales Guidance of $720.000M-$760.000M vs $735.000M Est

Emergent BioSolutions (NYSE:EBS) affirms FY2026 sales outlook from $720.000 million-$760.000 million

benzinga.com
Emergent BioSolutions Q1 Adj. EPS $0.21 Beats $(0.25) Estimate, Sales $156.100M Beat $145.000M Estim

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.21 per share which beat the analy

Emergent BioSolutions Reports First Quarter 2026 Financial Results
globenewswire.com
Emergent BioSolutions Reports First Quarter 2026 Financial Results

GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today r

benzinga.com
Emergent BioSolutions Receives Singapore's Health Sciences Authority Approval For Expanded Indicatio

Emergent BioSolutions Inc. (NYSE:EBS) today announced that Singapore's Health Sciences Authority

Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
globenewswire.com
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indica

GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today a

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

benzinga.com
Emergent BioSolutions Signs Multi-Year, ~$50M Agreement With SAB Biotherapeutics For Development And

The executed agreement is valued at approximately $50 million, of which $36 million is contingent on

Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
globenewswire.com
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to

GAITHERSBURG, Md., April 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today a

Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
globenewswire.com
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness

WINNIPEG, Manitoba, April 29, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE: EBS) anno

benzinga.com
Emergent BioSolutions Signs ~$34.5M Agreement With Substipharm Biologics Over Drug Substance Product

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has entered into an agreement with Substiph

Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
globenewswire.com
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Supp

GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: E

Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS
seekingalpha.com
Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS

The April/May 2026 Ben Graham All-Star Value Dogs list highlights 14 'safer,' fair-priced large-cap

Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
globenewswire.com
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026

GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will ho

Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
globenewswire.com
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Incre

Refinancing extends maturities, reduces interest expense and positions Emergent for durable, long-te

benzinga.com
Emergent BioSolutions Collaborates With B.C. Provincial Health Services Authority To Provide Nasal S

Emergent BioSolutions (NYSE:EBS) announced that it has partnered with the B.C. Provincial Health Ser

Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
globenewswire.com
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of

WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) annou

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
globenewswire.com
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside Colleg

New product offerings and educational initiative, Ready to Rescue, aim to increase access and adopti

Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
globenewswire.com
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a glob

benzinga.com
Emergent BioSolutions Secures ~$54M Contract To Provide CNJ-016 Vaccinia Immune Globulin Intravenous

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at app

benzinga.com
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) wit

Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
benzinga.com
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving

Nasdaq Down Over 1%; Dell Shares Jump After Q4 Results
benzinga.com
Nasdaq Down Over 1%; Dell Shares Jump After Q4 Results

U.S. stocks down mid-trading, Nasdaq falls 1%. Dow down 1.40%, S&P 500 falls 0.74%. Dell shares

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Dow Dips Over 600 Points; US Producer Prices Increase In January
benzinga.com
Dow Dips Over 600 Points; US Producer Prices Increase In January

US stocks traded lower, Dow down 600 points. Nasdaq and S&P also fell. Consumer staples up, tech

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premark

Earnings Summary: Emergent BioSolutions Q4
benzinga.com
Earnings Summary: Emergent BioSolutions Q4

benzinga.com
Emergent BioSolutions Sees FY2026 Sales $720.000M-$760.000M vs $1.155B Est

Emergent BioSolutions (NYSE:EBS) sees FY2026 sales of $720.000 million-$760.000 million vs $1.155 bi

benzinga.com
Emergent BioSolutions Q4 Adj. EPS $(0.43) Misses $0.11 Estimate, Sales $148.700M Miss $217.500M Esti

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.43) per share which missed the ana

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Emergent BioSolutions Wins FDA Approval For New Narcan Multipacks To Expand Overdose Access
benzinga.com
Emergent BioSolutions Wins FDA Approval For New Narcan Multipacks To Expand Overdose Access

Emergent BioSolutions Inc. (EBS) stock rose Friday as FDA approved new multipack configurations of o

benzinga.com
Emergent BioSolutions Obtains FDA Approval For Its Supplemental New Drug Application For New Multipa

Today, Emergent BioSolutions (NYSE:EBS) announced that the U.S. Food and Drug Administration (FDA) h